ADHD Trial, Recruiting (NCT06553430)

ADHD Trial, Recruiting NCT06553430 Sponsor: Harbin Medical University Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT06553430 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child has been clinically diagnosed with ADHD
The child is between 7 and 14 years old
The child has scored 80 or above on a standard cognitive ability test called the Combined Raven's Test
The child is not currently receiving any other form of treatment apart from medication
The child is physically able to take part in sports and exercise activities
The child's family has been assessed as having a close or highly connected family relationship (confirm with trial site)
The family is willing to participate voluntarily and has signed a consent form

Who may not be able to join:

The child has a history of epileptic seizures
The child has been diagnosed with any other mental health or movement-related condition
The child has a visual impairment
The child is currently taking any other medications that affect mood, behaviour, or mental health
The child has other existing health conditions alongside their ADHD (confirm with trial site)
The child has a serious ongoing illness such as severe heart, brain, kidney, or lung disease, or has been diagnosed with a tumour

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06553430

Sponsor: Harbin Medical University

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

More information: https://clinicaltrials.gov/study/NCT06553430

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child has been clinically diagnosed with ADHD
The child is between 7 and 14 years old
The child has scored 80 or above on a standard cognitive ability test called the Combined Raven's Test
The child is not currently receiving any other form of treatment apart from medication
The child is physically able to take part in sports and exercise activities
The child's family has been assessed as having a close or highly connected family relationship (confirm with trial site)
The family is willing to participate voluntarily and has signed a consent form

Who may not be able to join:

The child has a history of epileptic seizures
The child has been diagnosed with any other mental health or movement-related condition
The child has a visual impairment
The child is currently taking any other medications that affect mood, behaviour, or mental health
The child has other existing health conditions alongside their ADHD (confirm with trial site)
The child has a serious ongoing illness such as severe heart, brain, kidney, or lung disease, or has been diagnosed with a tumour

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Harbin Medical University

Registry

ClinicalTrials.gov

Start date

28 November 2023

Est. completion

1 October 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

ADHD core symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov